Treatment of Crohn's disease with Infliximab - An initial community practice experience.

被引:7
|
作者
McCabe, RP [1 ]
Schwartz, RM [1 ]
Bebeau, V [1 ]
Tatarek, N [1 ]
Weinberg, DI [1 ]
机构
[1] Minnesota Gastroenterol PA, Minneapolis, MN USA
关键词
D O I
10.1016/S0016-5085(00)84403-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
2965
引用
收藏
页码:A567 / A567
页数:1
相关论文
共 50 条
  • [41] Profile of infliximab in the treatment of pediatric Crohn's disease
    Kierkus, Jaroslaw
    Szymanska, Edyta
    Oracz, Grzegorz
    Wiernicka, Anna
    Dadalski, Maciej
    PEDIATRIC HEALTH MEDICINE AND THERAPEUTICS, 2015, 6 : 79 - 85
  • [42] Treatment of severe esophageal Crohn's disease with infliximab
    Heller, T
    James, SP
    Drachenberg, C
    Hernandez, C
    Darwin, PE
    INFLAMMATORY BOWEL DISEASES, 1999, 5 (04) : 279 - 282
  • [43] Toxicity of infliximab in the course of treatment of Crohn's disease
    Bratcher, JM
    Korelitz, BI
    EXPERT OPINION ON DRUG SAFETY, 2006, 5 (01) : 9 - 16
  • [44] Infliximab for the treatment of fistulas in patients with Crohn's disease
    Present, DH
    Rutgeerts, P
    Targan, S
    Hanauer, SB
    Mayer, L
    van Hogezand, RA
    Podolsky, DK
    Sands, BE
    Braakman, T
    DeWoody, KL
    Schaible, TF
    van Deventer, SJH
    NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (18): : 1398 - 1405
  • [45] Myelolipoma After Infliximab Treatment for Crohn's Disease
    Cesa, Kevin
    Puppa, Elaine Leonard
    Eslami, Katayoun
    Blanchard, Samra M.
    Watkins, Runa D.
    ACG CASE REPORTS JOURNAL, 2022, 9 (07)
  • [46] Infliximab treatment for Crohn's disease arthritis.
    Ellman, MH
    Hanauer, S
    Sitran, M
    Cohen, R
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S299 - S299
  • [47] Risks and benefits of infliximab for the treatment of Crohn's disease
    Siegel, Corey A.
    Hur, Chin
    Korzenik, Joshua R.
    Gazelle, G. Scott
    Sands, Bruce E.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (08) : 1017 - 1024
  • [48] Natalizumab in complicated Crohn's disease: A single center experience.
    Sheikh, S.
    Plevy, S.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (12) : S22 - S22
  • [49] The safety profile of infliximab for Crohn's disease in clinical practice: The Mayo clinic experience in 500 patients
    Colombel, JF
    Loftus, EV
    Tremaine, WJ
    Egan, LJ
    Harmsen, WS
    Schleck, CD
    Zinsmeister, AR
    Sandborn, WJ
    GASTROENTEROLOGY, 2003, 124 (04) : A7 - A7
  • [50] Infliximab in Crohn's disease
    Sáez, LR
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2004, 96 (06) : 359 - 363